findmyKOL

Wanpen Vongpatanasin, MD

Enriched profile

Professor, Department of Internal Medicine; Director, Hypertension Section, Division of Cardiology; Program Director, Hypertension Fellowship Program; Director, AHA Comprehensive Hypertension Center · University of Texas Southwestern Medical Center

ORCIDNPI
Region🇺🇸 Dallas, TX · South Central · United StatesSpecialtyCardiovascular DiseaseFocusHeart Rate Variability and Autonomic Control+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2002–2026

Wanpen Vongpatanasin is Professor, Department of Internal Medicine; Director, Hypertension Section, Division of Cardiology; Program Director, Hypertension Fellowship Program; Director, AHA Comprehensive Hypertension Center at University of Texas Southwestern Medical Center. OpenAlex indexes 325 publications with 9,480 citations (h-index 52); ClinicalTrials.gov lists 14 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Wanpen Vongpatanasin, MD, is Professor, Department of Internal Medicine at University of Texas Southwestern Medical Center. The public record shows 325 publications with 9,480 citations (h-index 52), centered on Heart Rate Variability and Autonomic Control, Blood Pressure and Hypertension Studies, Cardiovascular and exercise physiology. It also documents an investigator role on 14 registered clinical trials, industry payments reported by 3 companies, 9 NIH-funded awards (2002–2026).

  • Most recent indexed publication: 2026 · European journal of preventive cardiology
  • Top research focus: Heart Rate Variability and Autonomic Control
  • 14 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Hypertension12 trialsAlzheimer's / Dementia1 trialCognitive Dysfunction1 trialDementia1 trialObesity1 trialObesity, Abdominal1 trialChronic Kidney Disease1 trialCoronary Artery Disease / ACS1 trialCoronary Artery Disease1 trial

Research focus

OpenAlex concept fingerprint
Heart Rate Variability and Autonomic ControlBlood Pressure and Hypertension StudiesCardiovascular and exercise physiologyCardiovascular Health and Disease PreventionHormonal Regulation and Hypertension

Works with

trial sponsors and companies reporting payments
University of Texas Southwestern Medical CenterClinical trials12Industry paymentsAstraZeneca Pharmaceuticals LPClinical trialsIndustry payments4HeartFlow, Inc.Clinical trialsIndustry payments2

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
325publications

Distinct works indexed by OpenAlex, matched via ORCID; 24 in PubMed.

9,480citations

Total citations across indexed works.

52h-index

Hirsch index (OpenAlex). i10-index 123.

Clinical & industry

trials, payments and federal funding
14clinical trials

Investigator role on registered studies.

View trials
3companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
9NIH grants · 2002–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 14 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    Angiotensin receptor blocker (ARB)24.8%
    Olmesartan Medoxomil58%Losartan Potassium42%
    Part D<11 patients
    Calcium channel blocker18.1%
    Amlodipine Besylate100%
    Part D<11 patients
Where care is delivered (Part B)83.9% facility · 16.1% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

9 NIH research awards on record, funded 20022026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Scott A. Smith70Masaki Mizuno60Gary A. Iwamoto48

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/wanpen-vongpatanasin-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • Other

    profiles.utsouthwestern.edu/profile/17620/wanpen-vongpatanasin.html

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu
  • ResearchGate

    researchgate.net/profile/Wanpen-Vongpatanasin

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net
1 more verified account behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/p/DQPIlcVDvOX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • X / Twitter

    x.com/utswheart

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances
  • Guest

    The Curbsiders podcast, Episode #254: "Hypertension Update with Dr. Wanpen Vongpatanasin" (Feb 1, 2021) - discussed BP monitoring thresholds, measurement technique, and first-line pharmacotherapy

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thecurbsiders.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.